Ensysce Biosciences stock price
엔시스 바이오사이언시스NASDAQ:ENSC · Nasdaq · Healthcare$0.3950-1.20%
2026-10-02 closeLoading chart…
Today's signals · No active technical signal.
Signal details →Ensysce Biosciences last closed at $0.3950 (-1.20%) on 2026-10-02. Listed on Nasdaq. Trailing 12 months PER is -0.4×. Its overall grade ranks 281 of 739 stocks in Healthcare.
About this company
Ensysce Biosciences last closed at $0.3950 (-1.20%) on 2026-10-02. Listed on Nasdaq.
Details →Reported results
Details →
Position in sector
Healthcare · Overall B+ · 281/739
Valuation grade A-
Related stocks
- Purdue PharmaCompetitor
오피오이드 남용 억제 진통제 시장에서 유사한 안전성 중심 처방약 경쟁 축
- PfizerCompetitor
중추신경계·통증 치료제 포함 제약 대기업으로 개발 파이프라인 경쟁
- Johnson & JohnsonCompetitor
제약 사업부를 통해 진통제·마약성 진통제 대체 치료제 분야 경쟁
About Ensysce Biosciences
- What technical signals does Ensysce Biosciences (ENSC) have?
- Ensysce Biosciences current technical signals: no active technical signal.
- Is Ensysce Biosciences a cup-and-handle pattern?
- No. Ensysce Biosciences has no valid Cup signal right now.
- What published figures are available for Ensysce Biosciences?
- Market cap: $1.4M. Trailing 12 months PER: -0.4×. Latest quarter PBR: -4.64×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-04 dataset
Turn what you saw on this name into a strategy
Ask Q about Ensysce Biosciences, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.
Quantus Signal · live data · not investment advice · Privacy Policy